Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: CNS Drugs. 2019 Dec;33(12):1155–1166. doi: 10.1007/s40263-019-00684-6

Table 1:

Drugs that cause synthetic lethality in IDH1 mutated neoplasms

Type Compound Name Target References
Drugs GMX1778, FK866 NAMPT [29]
Temozolomide DNA-damage [30]
CB-839 Glutaminase inhibitor [31]
PARP inhibitors PARP [32], [54]
ABT199 Bcl-2 [19]
ABT263 Bcl-xL (Bcl-2) [38]
Radiation DNA-damage [26]